Funding
Funding not disclosed
Founders
Product
Problem
Men experiencing frequent nighttime urination and reduced urinary flow often face disruptions to their sleep and daily activities. These symptoms are frequently linked to prostate enlargement, which can be exacerbated by hormonal factors like dihydrotestosterone (DHT).
Solution
STĒLO offers a dietary supplement formulated with clinically studied ingredients to address prostate health and improve urinary function. The formulation targets DHT, a key hormone implicated in prostate growth, to help reduce nighttime urinary urgency and enhance urine flow. By addressing the root cause of these symptoms, STĒLO aims to provide noticeable improvements within a 30-day period.
Target Audience
The primary target audience consists of adult men experiencing symptoms of benign prostatic hyperplasia (BPH), such as nocturia and diminished urinary flow.
Features
- Contains equol, a compound shown to bind directly to DHT, potentially reducing its activity in the prostate.
- Includes saw palmetto, recognized for its role in managing DHT levels and supporting smoother urination.
- Formulated with green tea extract, rich in antioxidants that may help combat inflammation and support healthy prostate cell growth.
- Features beta sitosterol, a plant sterol studied for its ability to support urinary flow and reduce residual urine volume.
- Incorporates lycopene, an antioxidant linked to prostate health and the reduction of oxidative stress.
- Includes a bioavailable form of vitamin E to protect prostate tissue from oxidative damage and support overall resilience.